Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
about
RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinomaEvolving role of Sorafenib in the management of hepatocellular carcinoma.Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinoma.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.Advances and Future Directions in the Treatment of Hepatocellular CarcinomaSurvival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era.Current Status of Sorafenib Use for Treatment of Hepatocellular Carcinoma.Top ten errors of statistical analysis in observational studies for cancer research.Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.ReplyThe prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis
P2860
Q33688694-6DC565F3-F950-4106-950E-05E9E212D356Q33779864-E5A7DDA3-4A2B-4929-8493-DFC61BAF2DBCQ33913172-B92245C3-D1A9-4072-92D3-0C8684B6ECC2Q38697003-A433F148-04B6-40F1-8BBE-93A9DC1377E7Q38702281-6A536993-AC69-4FE2-9057-54D471531C9AQ41531360-BCDE8041-C9C5-4F1B-9E41-79513F1F22F9Q44761183-593360D2-A8AE-4586-86C2-0B51F3E5D415Q47116072-6AB34548-CC48-4350-905C-68607A203340Q47346382-9A3F5CA6-0965-41DB-9979-248C6FE9AFD0Q55315687-3444FCB4-B7FF-4D55-BFED-9931AD3BD484Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524FQ58787250-38C97A88-B098-45F9-8427-18BF7CD114AF
P2860
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@ast
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@en
type
label
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@ast
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@en
prefLabel
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@ast
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@en
P2093
P2860
P356
P1433
P1476
Survival and cost-effectivenes ...... of the SEER-Medicare database.
@en
P2093
Amit G Singal
Anna S Lok
Hari Nathan
Neehar D Parikh
Rajesh Balkrishnan
Vahakn Shahinian
Vincent D Marshall
P2860
P304
P356
10.1002/HEP.28881
P407
P577
2016-10-22T00:00:00Z